MUTATIONAL ANALYSIS OF THE CYSTIC FIBROSIS GENE
囊性纤维化基因的突变分析
基本信息
- 批准号:3874794
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:biochemical evolution cystic fibrosis gene deletion mutation gene mutation genetic polymorphism genetic terminator element membrane permeability membrane proteins molecular pathology nucleic acid hybridization point mutation polymerase chain reaction protein transport restriction mapping transport proteins
项目摘要
The recent identification of the cystic fibrosis (CF) gene, the cystic
fibrosis transmembrane conductance regulator (CFTR) gene (Riordan JR et
al., Science 1989;245:1066-73), revealed that the gene belongs to a family
of membrane transport molecules that includes the multi-drug resistance
genes. Approximately 70% of CF chromosomes contain a deletion of 3-base
pairs resulting in the loss of a phenylalanine codon at amino acid position
508 (delta F508). The focus of this project is to identify new mutations in
this gene that comprise the remaining 30% of CFTR gene mutations. Using
oligonucleotide primers based on the sequence of the CFTR gene, we have
used the polymerase chain reaction to amplify several coding exons. These
regions have been examined from 110 patients that contain 127 chromosomes
without the common CF mutation (delta F508). Eight additional mutations
have been identified in this group, in a total of four different exons.
Most of the mutations were initially identified using an assay for single--
stranded conformation polymorphisms. All mutations were subsequently
characterized by direct sequencing of the amplified DNA and can be assayed
by restriction enzyme digestion or allele-specific oligonucleotide
hybridization.
The mutations fall into two classes: (1) one or two nucleotide insertions
and deletions that introduce termination codons into the gene and are
predicted to result in severely truncated protein products, and (2) point
mutations in the putative membrane-spanning domains that replace charged
amino acids with nonpolar residues. Sequencing of the membrane-spanning
region from several species demonstrates that this region is highly
conserved across species.
最近发现了囊性纤维化(CF)基因,即囊性纤维化基因,
纤维化跨膜传导调节因子(CFTR)基因(Riordan JR et
例如,Science 1989;245:1066-73),揭示了该基因属于一个家族,
包括多药耐药性的膜转运分子
基因.大约70%的CF染色体含有3个碱基的缺失
导致氨基酸位置上苯丙氨酸密码子丢失的配对
508(Δ F508)。该项目的重点是确定新的突变,
该基因包含剩余的30%的CFTR基因突变。使用
基于CFTR基因序列的寡核苷酸引物,我们
用聚合酶链反应扩增了几个编码外显子。这些
已检查了110名患者的包含127条染色体的区域
没有常见的CF突变(Δ F508)。八个额外的突变
在这个组中已经确定,总共有四个不同的外显子。
大多数突变最初都是使用单一的检测方法鉴定的,
链构象多态性所有突变随后
其特征在于对扩增的DNA进行直接测序,
通过限制酶消化或等位基因特异性寡核苷酸
杂交方法
突变分为两类:(1)一个或两个核苷酸插入
和将终止密码子引入基因的缺失,
预测导致严重截短的蛋白质产物,和(2)点
在假定的跨膜结构域中的突变,
具有非极性残基的氨基酸。跨膜序列测定
从几个物种的区域表明,该地区是高度
在物种间是保守的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN J O'BRIEN其他文献
STEPHEN J O'BRIEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN J O'BRIEN', 18)}}的其他基金
The Development of the Domestic cat, Felis catus, as an
家猫(Felis catus)的发展
- 批准号:
6558902 - 财政年份:
- 资助金额:
-- - 项目类别:
The Genetic Structure of Natural Populations of Past and Present
过去和现在自然种群的遗传结构
- 批准号:
6433019 - 财政年份:
- 资助金额:
-- - 项目类别:
Reproductive Strategies in Animal Species Emphasizing Developmental Biology
强调发育生物学的动物物种的生殖策略
- 批准号:
6433022 - 财政年份:
- 资助金额:
-- - 项目类别:
Comparative Genomics: Mechanism(s) Against Emerging Infectious Diseases
比较基因组学:对抗新发传染病的机制
- 批准号:
7965401 - 财政年份:
- 资助金额:
-- - 项目类别:
The Genetic Structure of Natural Populations Past and Present
过去和现在自然种群的遗传结构
- 批准号:
7732873 - 财政年份:
- 资助金额:
-- - 项目类别:
Reproductive Strategies in Animal Species Emphasizing Developmental Biology
强调发育生物学的动物物种的生殖策略
- 批准号:
8157175 - 财政年份:
- 资助金额:
-- - 项目类别:
The Genetic Structure of Natural Populations Past and Present
过去和现在自然种群的遗传结构
- 批准号:
8157173 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Rapid detection of Pseudomonas aeruginosa in people with cystic fibrosis
快速检测囊性纤维化患者中的铜绿假单胞菌
- 批准号:
10103495 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Collaborative R&D
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants
合理优化治疗罕见囊性纤维化变异的组合疗法
- 批准号:
10736732 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Pulmonary delivery of base editors for gene therapy of cystic fibrosis with nonsense mutations
肺部递送碱基编辑器用于无义突变囊性纤维化的基因治疗
- 批准号:
488681 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Analysis of synthetic derivatives with reduced lipophilicity as candidate potentiators towards better treatment alternatives for Cystic Fibrosis
分析亲脂性降低的合成衍生物作为候选增效剂,以获得更好的囊性纤维化治疗替代方案
- 批准号:
481159 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Developing Gene Editing Therapeutics, Biodegradable Polymeric Delivery Vehicles, and High-throughput Platforms for the Treatment of Cystic Fibrosis
开发用于治疗囊性纤维化的基因编辑疗法、可生物降解的聚合物递送载体和高通量平台
- 批准号:
10836095 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A Ginsenoside TMEM16A Potentiator for Cystic Fibrosis
人参皂苷 TMEM16A 治疗囊性纤维化的增效剂
- 批准号:
10574384 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Computationally-Inspired Design of Non-Viral Gene Delivery Vehicles for mRNA-Based Cystic Fibrosis Therapies
用于基于 mRNA 的囊性纤维化治疗的非病毒基因传递载体的计算启发设计
- 批准号:
10760605 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Health Outcomes of Parents with Cystic Fibrosis (HOPe:CF)
患有囊性纤维化的父母的健康结果 (HOPe:CF)
- 批准号:
10581321 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Preparation for lung transplant discussions and decisions among people with cystic fibrosis
囊性纤维化患者肺移植讨论和决策的准备
- 批准号:
10657027 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10716654 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




